| Title |
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial
|
|---|---|
| Published in |
Journal of Neuro-Oncology, May 2019
|
| DOI | 10.1007/s11060-019-03175-2 |
| Pubmed ID | |
| Authors |
Sara Pedretti, Laura Masini, Enrico Turco, Luca Triggiani, Marco Krengli, Bruno Meduri, Luigi Pirtoli, Paolo Borghetti, Ludovica Pegurri, Nada Riva, Roberto Gatta, Vincenzo Fusco, Silvia Scoccianti, Alessio Bruni, Umberto Ricardi, Riccardo Santoni, Stefano M. Magrini, Michela Buglione |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 2 | 40% |
| Mexico | 1 | 20% |
| Greece | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 31 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 16% |
| Researcher | 4 | 13% |
| Student > Doctoral Student | 3 | 10% |
| Professor | 1 | 3% |
| Lecturer | 1 | 3% |
| Other | 2 | 6% |
| Unknown | 15 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 32% |
| Engineering | 3 | 10% |
| Neuroscience | 2 | 6% |
| Nursing and Health Professions | 1 | 3% |
| Unknown | 15 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2019.
All research outputs
#7,533,308
of 23,144,579 outputs
Outputs from Journal of Neuro-Oncology
#1,047
of 2,997 outputs
Outputs of similar age
#137,283
of 349,745 outputs
Outputs of similar age from Journal of Neuro-Oncology
#29
of 56 outputs
Altmetric has tracked 23,144,579 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,997 research outputs from this source. They receive a mean Attention Score of 4.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,745 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.